December 8th, 2010 by admin
Experimental drug Contrave(R) (naltrexone SR/bupropion SR) for the treatment of obesity has been recommended for approval by the FDA’s Endocrinologic and Metabolic Drugs Advisory Committee. The Committee (Panel) voted 13 to 7 in favor of approving Contrave for long-term use among certain obese and overweight patients… Related Blogs CreativeLive: Experimental Portraiture with Jeremy Cowart Day [...]
Read the rest »
October 31st, 2010 by admin
VIVUS, Inc. (Nasdaq: VVUS) announced that it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for the investigational new drug QNEXA® (phentermine/topiramate) Controlled-Release Capsules. The FDA issued the CRL to communicate its decision that the NDA cannot be approved in its present form… [...]
Read the rest »
October 23rd, 2010 by admin
American Medical Aesthetics & Wellness is excited and proud to announce a new and effective treatment for body contouring and weight loss. The Zerona® Laser is the first FDA-approved, non-invasive body contouring procedure that effectively removes undesirable excess fat
Read the rest »
September 30th, 2010 by admin
Title: FDA: Popular Mouthwashes Make False ClaimsCategory: Health NewsCreated: 9/29/2010 6:00:00 AMLast Editorial Review: 9/29/2010 6:00:09 AM Related Blogs FDA: Popular Mouthwashes Make False Claims | Diet Care Commentary » Blog Archive » False Hope FDA: Infant Sleep 'positioners' Unsafe Phinney elated with superb third world championship title False Advertising 5 Essential Principles to Make [...]
Read the rest »